Multiple Myeloma Therapeutics Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiple Myeloma Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2032
1.2.2 Chemotherapy
1.2.3 Radiation
1.2.4 Stem Cell Transplant
1.2.5 Other Supportive Treatments
1.3 Market by Application
1.3.1 Global Multiple Myeloma Therapeutics Market Share by Application: 2018 VS 2022 VS 2032
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Multiple Myeloma Therapeutics Market Perspective (2018-2032)
2.2 Multiple Myeloma Therapeutics Growth Trends by Region
2.2.1 Multiple Myeloma Therapeutics Market Size by Region: 2018 VS 2022 VS 2032
2.2.2 Multiple Myeloma Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Multiple Myeloma Therapeutics Forecasted Market Size by Region (2023-2032)
2.3 Multiple Myeloma Therapeutics Market Dynamics
2.3.1 Multiple Myeloma Therapeutics Industry Trends
2.3.2 Multiple Myeloma Therapeutics Market Drivers
2.3.3 Multiple Myeloma Therapeutics Market Challenges
2.3.4 Multiple Myeloma Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multiple Myeloma Therapeutics Players by Revenue
3.1.1 Global Top Multiple Myeloma Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Multiple Myeloma Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Multiple Myeloma Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multiple Myeloma Therapeutics Revenue
3.4 Global Multiple Myeloma Therapeutics Market Concentration Ratio
3.4.1 Global Multiple Myeloma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiple Myeloma Therapeutics Revenue in 2022
3.5 Multiple Myeloma Therapeutics Key Players Head office and Area Served
3.6 Key Players Multiple Myeloma Therapeutics Product Solution and Service
3.7 Date of Enter into Multiple Myeloma Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiple Myeloma Therapeutics Breakdown Data by Type
4.1 Global Multiple Myeloma Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Multiple Myeloma Therapeutics Forecasted Market Size by Type (2023-2032)
5 Multiple Myeloma Therapeutics Breakdown Data by Application
5.1 Global Multiple Myeloma Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Multiple Myeloma Therapeutics Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Multiple Myeloma Therapeutics Market Size (2018-2032)
6.2 North America Multiple Myeloma Therapeutics Market Size by Country (2018-2023)
6.3 North America Multiple Myeloma Therapeutics Market Size by Country (2023-2032)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Multiple Myeloma Therapeutics Market Size (2018-2032)
7.2 Europe Multiple Myeloma Therapeutics Market Size by Country (2018-2023)
7.3 Europe Multiple Myeloma Therapeutics Market Size by Country (2023-2032)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multiple Myeloma Therapeutics Market Size (2018-2032)
8.2 Asia-Pacific Multiple Myeloma Therapeutics Market Size by Country (2018-2023)
8.3 Asia-Pacific Multiple Myeloma Therapeutics Market Size by Country (2023-2032)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Multiple Myeloma Therapeutics Market Size (2018-2032)
9.2 Latin America Multiple Myeloma Therapeutics Market Size by Country (2018-2023)
9.3 Latin America Multiple Myeloma Therapeutics Market Size by Country (2023-2032)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multiple Myeloma Therapeutics Market Size (2018-2032)
10.2 Middle East & Africa Multiple Myeloma Therapeutics Market Size by Country (2018-2023)
10.3 Middle East & Africa Multiple Myeloma Therapeutics Market Size by Country (2023-2032)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Janssen Biotech, Inc.
11.1.1 Janssen Biotech, Inc. Company Detail
11.1.2 Janssen Biotech, Inc. Business Overview
11.1.3 Janssen Biotech, Inc. Multiple Myeloma Therapeutics Introduction
11.1.4 Janssen Biotech, Inc. Revenue in Multiple Myeloma Therapeutics Business (2018-2023)
11.1.5 Janssen Biotech, Inc. Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Detail
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Multiple Myeloma Therapeutics Introduction
11.2.4 Bristol-Myers Squibb Revenue in Multiple Myeloma Therapeutics Business (2018-2023)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Detail
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Multiple Myeloma Therapeutics Introduction
11.3.4 Novartis AG Revenue in Multiple Myeloma Therapeutics Business (2018-2023)
11.3.5 Novartis AG Recent Development
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Company Detail
11.4.2 Bristol-Myers Squibb Company Business Overview
11.4.3 Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Introduction
11.4.4 Bristol-Myers Squibb Company Revenue in Multiple Myeloma Therapeutics Business (2018-2023)
11.4.5 Bristol-Myers Squibb Company Recent Development
11.5 Millennium Pharmaceuticals
11.5.1 Millennium Pharmaceuticals Company Detail
11.5.2 Millennium Pharmaceuticals Business Overview
11.5.3 Millennium Pharmaceuticals Multiple Myeloma Therapeutics Introduction
11.5.4 Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapeutics Business (2018-2023)
11.5.5 Millennium Pharmaceuticals Recent Development
11.6 Celgene Corporation
11.6.1 Celgene Corporation Company Detail
11.6.2 Celgene Corporation Business Overview
11.6.3 Celgene Corporation Multiple Myeloma Therapeutics Introduction
11.6.4 Celgene Corporation Revenue in Multiple Myeloma Therapeutics Business (2018-2023)
11.6.5 Celgene Corporation Recent Development
11.7 Kesios Therapeutics Limited
11.7.1 Kesios Therapeutics Limited Company Detail
11.7.2 Kesios Therapeutics Limited Business Overview
11.7.3 Kesios Therapeutics Limited Multiple Myeloma Therapeutics Introduction
11.7.4 Kesios Therapeutics Limited Revenue in Multiple Myeloma Therapeutics Business (2018-2023)
11.7.5 Kesios Therapeutics Limited Recent Development
11.8 Amgene, Inc.
11.8.1 Amgene, Inc. Company Detail
11.8.2 Amgene, Inc. Business Overview
11.8.3 Amgene, Inc. Multiple Myeloma Therapeutics Introduction
11.8.4 Amgene, Inc. Revenue in Multiple Myeloma Therapeutics Business (2018-2023)
11.8.5 Amgene, Inc. Recent Development
11.9 Genzyme Corporation
11.9.1 Genzyme Corporation Company Detail
11.9.2 Genzyme Corporation Business Overview
11.9.3 Genzyme Corporation Multiple Myeloma Therapeutics Introduction
11.9.4 Genzyme Corporation Revenue in Multiple Myeloma Therapeutics Business (2018-2023)
11.9.5 Genzyme Corporation Recent Development
11.10 Juno Therapeutics
11.10.1 Juno Therapeutics Company Detail
11.10.2 Juno Therapeutics Business Overview
11.10.3 Juno Therapeutics Multiple Myeloma Therapeutics Introduction
11.10.4 Juno Therapeutics Revenue in Multiple Myeloma Therapeutics Business (2018-2023)
11.10.5 Juno Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Multiple Myeloma Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2032
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation
Table 4. Key Players of Stem Cell Transplant
Table 5. Key Players of Other Supportive Treatments
Table 6. Global Multiple Myeloma Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2032
Table 7. Global Multiple Myeloma Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2032
Table 8. Global Multiple Myeloma Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Multiple Myeloma Therapeutics Market Share by Region (2018-2023)
Table 10. Global Multiple Myeloma Therapeutics Forecasted Market Size by Region (2023-2032) & (US$ Million)
Table 11. Global Multiple Myeloma Therapeutics Market Share by Region (2023-2032)
Table 12. Multiple Myeloma Therapeutics Market Trends
Table 13. Multiple Myeloma Therapeutics Market Drivers
Table 14. Multiple Myeloma Therapeutics Market Challenges
Table 15. Multiple Myeloma Therapeutics Market Restraints
Table 16. Global Multiple Myeloma Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Multiple Myeloma Therapeutics Market Share by Players (2018-2023)
Table 18. Global Top Multiple Myeloma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Myeloma Therapeutics as of 2022)
Table 19. Ranking of Global Top Multiple Myeloma Therapeutics Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Multiple Myeloma Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Multiple Myeloma Therapeutics Product Solution and Service
Table 23. Date of Enter into Multiple Myeloma Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Multiple Myeloma Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Multiple Myeloma Therapeutics Revenue Market Share by Type (2018-2023)
Table 27. Global Multiple Myeloma Therapeutics Forecasted Market Size by Type (2023-2032) & (US$ Million)
Table 28. Global Multiple Myeloma Therapeutics Revenue Market Share by Type (2023-2032)
Table 29. Global Multiple Myeloma Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Multiple Myeloma Therapeutics Revenue Market Share by Application (2018-2023)
Table 31. Global Multiple Myeloma Therapeutics Forecasted Market Size by Application (2023-2032) & (US$ Million)
Table 32. Global Multiple Myeloma Therapeutics Revenue Market Share by Application (2023-2032)
Table 33. North America Multiple Myeloma Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Multiple Myeloma Therapeutics Market Size by Country (2023-2032) & (US$ Million)
Table 35. Europe Multiple Myeloma Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Multiple Myeloma Therapeutics Market Size by Country (2023-2032) & (US$ Million)
Table 37. Asia-Pacific Multiple Myeloma Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Multiple Myeloma Therapeutics Market Size by Region (2023-2032) & (US$ Million)
Table 39. Latin America Multiple Myeloma Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 40. Latin America Multiple Myeloma Therapeutics Market Size by Country (2023-2032) & (US$ Million)
Table 41. Middle East & Africa Multiple Myeloma Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 42. Middle East & Africa Multiple Myeloma Therapeutics Market Size by Country (2023-2032) & (US$ Million)
Table 43. Janssen Biotech, Inc. Company Detail
Table 44. Janssen Biotech, Inc. Business Overview
Table 45. Janssen Biotech, Inc. Multiple Myeloma Therapeutics Product
Table 46. Janssen Biotech, Inc. Revenue in Multiple Myeloma Therapeutics Business (2018-2023) & (US$ Million)
Table 47. Janssen Biotech, Inc. Recent Development
Table 48. Bristol-Myers Squibb Company Detail
Table 49. Bristol-Myers Squibb Business Overview
Table 50. Bristol-Myers Squibb Multiple Myeloma Therapeutics Product
Table 51. Bristol-Myers Squibb Revenue in Multiple Myeloma Therapeutics Business (2018-2023) & (US$ Million)
Table 52. Bristol-Myers Squibb Recent Development
Table 53. Novartis AG Company Detail
Table 54. Novartis AG Business Overview
Table 55. Novartis AG Multiple Myeloma Therapeutics Product
Table 56. Novartis AG Revenue in Multiple Myeloma Therapeutics Business (2018-2023) & (US$ Million)
Table 57. Novartis AG Recent Development
Table 58. Bristol-Myers Squibb Company Company Detail
Table 59. Bristol-Myers Squibb Company Business Overview
Table 60. Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Product
Table 61. Bristol-Myers Squibb Company Revenue in Multiple Myeloma Therapeutics Business (2018-2023) & (US$ Million)
Table 62. Bristol-Myers Squibb Company Recent Development
Table 63. Millennium Pharmaceuticals Company Detail
Table 64. Millennium Pharmaceuticals Business Overview
Table 65. Millennium Pharmaceuticals Multiple Myeloma Therapeutics Product
Table 66. Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapeutics Business (2018-2023) & (US$ Million)
Table 67. Millennium Pharmaceuticals Recent Development
Table 68. Celgene Corporation Company Detail
Table 69. Celgene Corporation Business Overview
Table 70. Celgene Corporation Multiple Myeloma Therapeutics Product
Table 71. Celgene Corporation Revenue in Multiple Myeloma Therapeutics Business (2018-2023) & (US$ Million)
Table 72. Celgene Corporation Recent Development
Table 73. Kesios Therapeutics Limited Company Detail
Table 74. Kesios Therapeutics Limited Business Overview
Table 75. Kesios Therapeutics Limited Multiple Myeloma Therapeutics Product
Table 76. Kesios Therapeutics Limited Revenue in Multiple Myeloma Therapeutics Business (2018-2023) & (US$ Million)
Table 77. Kesios Therapeutics Limited Recent Development
Table 78. Amgene, Inc. Company Detail
Table 79. Amgene, Inc. Business Overview
Table 80. Amgene, Inc. Multiple Myeloma Therapeutics Product
Table 81. Amgene, Inc. Revenue in Multiple Myeloma Therapeutics Business (2018-2023) & (US$ Million)
Table 82. Amgene, Inc. Recent Development
Table 83. Genzyme Corporation Company Detail
Table 84. Genzyme Corporation Business Overview
Table 85. Genzyme Corporation Multiple Myeloma Therapeutics Product
Table 86. Genzyme Corporation Revenue in Multiple Myeloma Therapeutics Business (2018-2023) & (US$ Million)
Table 87. Genzyme Corporation Recent Development
Table 88. Juno Therapeutics Company Detail
Table 89. Juno Therapeutics Business Overview
Table 90. Juno Therapeutics Multiple Myeloma Therapeutics Product
Table 91. Juno Therapeutics Revenue in Multiple Myeloma Therapeutics Business (2018-2023) & (US$ Million)
Table 92. Juno Therapeutics Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiple Myeloma Therapeutics Market Share by Type: 2022 VS 2032
Figure 2. Chemotherapy Features
Figure 3. Radiation Features
Figure 4. Stem Cell Transplant Features
Figure 5. Other Supportive Treatments Features
Figure 6. Global Multiple Myeloma Therapeutics Market Share by Application in 2022 & 2032
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Multiple Myeloma Therapeutics Report Years Considered
Figure 11. Global Multiple Myeloma Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2032
Figure 12. Global Multiple Myeloma Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2032
Figure 13. Global Multiple Myeloma Therapeutics Market Share by Region: 2022 VS 2032
Figure 14. Global Multiple Myeloma Therapeutics Market Share by Players in 2022
Figure 15. Global Top Multiple Myeloma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Myeloma Therapeutics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Multiple Myeloma Therapeutics Revenue in 2022
Figure 17. North America Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 18. North America Multiple Myeloma Therapeutics Market Share by Country (2018-2032)
Figure 19. United States Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 20. Canada Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 21. Europe Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 22. Europe Multiple Myeloma Therapeutics Market Share by Country (2018-2032)
Figure 23. Germany Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 24. France Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 25. U.K. Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 26. Italy Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 27. Russia Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 28. Nordic Countries Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 29. Asia-Pacific Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 30. Asia-Pacific Multiple Myeloma Therapeutics Market Share by Region (2018-2032)
Figure 31. China Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 32. Japan Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 33. South Korea Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 34. Southeast Asia Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 35. India Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 36. Australia Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 37. Latin America Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 38. Latin America Multiple Myeloma Therapeutics Market Share by Country (2018-2032)
Figure 39. Mexico Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 40. Brazil Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 41. Middle East & Africa Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 42. Middle East & Africa Multiple Myeloma Therapeutics Market Share by Country (2018-2032)
Figure 43. Turkey Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 44. Saudi Arabia Multiple Myeloma Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 45. Janssen Biotech, Inc. Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2018-2023)
Figure 46. Bristol-Myers Squibb Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2018-2023)
Figure 47. Novartis AG Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2018-2023)
Figure 48. Bristol-Myers Squibb Company Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2018-2023)
Figure 49. Millennium Pharmaceuticals Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2018-2023)
Figure 50. Celgene Corporation Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2018-2023)
Figure 51. Kesios Therapeutics Limited Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2018-2023)
Figure 52. Amgene, Inc. Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2018-2023)
Figure 53. Genzyme Corporation Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2018-2023)
Figure 54. Juno Therapeutics Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Industry Market Size
